Xuanbin Wang
Impact in
- Pharmacology top 2%
- Berberine and alkaloids research
- Pharmacological Effects of Natural Compounds
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
Papers in
-
- Cancer, Hypoxia, and Metabolism 6
- Cancer, Lipids, and Metabolism 6
- Cancer-related molecular mechanisms research 5
-
- Berberine and alkaloids research 4
Xuanbin Wang
79 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 144
- Pharmacology 224
- Cancer Research 363
- Immunology 388
- Molecular Biology 1.1k
- Geriatrics and Gerontology 58
Countries citing papers authored by Xuanbin Wang
This map shows the geographic impact of Xuanbin Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuanbin Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuanbin Wang more than expected).
Fields of papers citing papers by Xuanbin Wang
This network shows the impact of papers produced by Xuanbin Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuanbin Wang. The network helps show where Xuanbin Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xuanbin Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 5 | |
| 4 | 2024 | 1 | |
| 5 | 2022 | 1 | |
| 6 | 2022 | 2 | |
| 7 | 2022 | 6 | |
| 8 | 2021 | 42 | |
| 9 | 2019 | 74 | |
| 10 | 2019 | 41 | |
| 11 | 2019 | 5 | |
| 12 | 2018 | 19 | |
| 13 | 2017 | 32 | |
| 14 | 2017 | 38 | |
| 15 | The Reactive Oxygen Species in Macrophage Polarization: Reflecting Its Dual Role in Progression and Treatment of Human Diseases Hit paper breakdown → | 2016 | 503 |
| 16 | 2016 | 10 | |
| 17 | 2014 | 40 | |
| 18 | 2013 | 17 | |
| 19 | 2013 | 24 | |
| 20 | 2012 | 25 |
About Xuanbin Wang
Xuanbin Wang is a scholar working on Cancer Research, Pharmacology, Molecular Biology, Oncology and Toxicology, having authored 83 papers that have together received 2.4k indexed citations. Recurring topics across this work include Natural product bioactivities and synthesis (8 papers), Cancer, Hypoxia, and Metabolism (6 papers), Cancer, Lipids, and Metabolism (6 papers), Cancer-related molecular mechanisms research (5 papers), Liver Disease Diagnosis and Treatment (5 papers), RNA Interference and Gene Delivery (4 papers), Cancer-related Molecular Pathways (4 papers) and Berberine and alkaloids research (4 papers). The work is most often cited by research in Pharmacology (224 citations), Cancer Research (363 citations), Immunology (388 citations), Molecular Biology (1.1k citations) and Geriatrics and Gerontology (58 citations). Xuanbin Wang has collaborated with scholars based in China, Hong Kong and Germany. Frequent co-authors include Yibin Feng, Ning Wang, Hor‐Yue Tan, Sha Li, Ming Hong, Fengjun Cao, Chen Li, Fan Cheung, Longchao Xiang and Xiaojun Cai. Their work appears in journals such as Frontiers in Pharmacology, International Journal of Molecular Sciences, Oncotarget, Gene and Food and Chemical Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.